# Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

> **NCT01707225** · PHASE1 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 10 (actual)

## Conditions studied

- Gastrointestinal Bleeding

## Interventions

- **DRUG:** Octreotide LAR Depot

## Key facts

- **NCT ID:** NCT01707225
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707225, "Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01707225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*